Results 221 to 230 of about 75,183 (262)
Some of the next articles are maybe not open access.
Hepatitis B Vaccine in a Hospital
Annals of Internal Medicine, 1984Excerpt To the editor: In their recent article, Dienstag and associates (1) report a high level of immune response in hospital personnel to hepatitis B vaccine.
D M, Schaaff +3 more
openaire +2 more sources
Hepatitis B Vaccination Safety
Annals of Pharmacotherapy, 2002BACKGROUND: Recent studies have suggested that adult hepatitis B vaccination may be associated with adverse reactions. OBJECTIVE: To further examine the relative risk, percentage association, and statistical significance of arthritic, immunologic, and gastrointestinal adverse reactions reported after adult hepatitis B vaccination compared with control ...
Mark R, Geier, David A, Geier
openaire +2 more sources
Indications for Hepatitis B Vaccine
JAMA: The Journal of the American Medical Association, 1982To the Editor.— I wish to take exception to some of Dr Saul Krugman's recommendations for the use of hepatitis B vaccine (1982;247:2012). I believe that he has defined too broadly the high-risk groups who should now receive this unusually expensive vaccine, which, initially, will probably be limited in availability.
openaire +2 more sources
American Journal of Gastroenterology, 2013
To the Editor: We read with great interest the article by Gisbert et al. (1), which investigated giving vaccine against hepatitis B virus (HBV) at an accelerated, double dosage in patients with inflammatory bowel disease (IBD). The overall seroconversion rate was low, particularly in those receiving biological therapy.
Jeanne, Tung +3 more
openaire +2 more sources
To the Editor: We read with great interest the article by Gisbert et al. (1), which investigated giving vaccine against hepatitis B virus (HBV) at an accelerated, double dosage in patients with inflammatory bowel disease (IBD). The overall seroconversion rate was low, particularly in those receiving biological therapy.
Jeanne, Tung +3 more
openaire +2 more sources
The Nurse Practitioner, 1983
Hepatitis B is a major public health problem. Complications of the disease can include a carrier state, chronic active hepatitis, cirrhosis and hepatocellular carcinoma. The development of hepatitis B virus vaccine has made active immunization against HBV possible.
openaire +2 more sources
Hepatitis B is a major public health problem. Complications of the disease can include a carrier state, chronic active hepatitis, cirrhosis and hepatocellular carcinoma. The development of hepatitis B virus vaccine has made active immunization against HBV possible.
openaire +2 more sources
Simultaneous Vaccination for Hepatitis A and B
Journal of Infectious Diseases, 1990Seronegative volunteers (15) were vaccinated at three 1-month intervals with a combined hepatitis A and B vaccine. The vaccine contained a killed hepatitis A vaccine made from hepatitis A virus (HAV) propagated in diploid human fibroblast cell cultures and hepatitis B surface antigen (HBsAg) produced in yeast.
B, Flehmig, U, Heinricy, M, Pfisterer
openaire +2 more sources
2017
Hepatitis A is a liver disease caused by the hepatitis A virus (HAV). The incubation period of hepatitis A is usually 14–28 days. Symptoms of hepatitis A range from mild to severe, and can include fever, malaise, loss of appetite, diarrhea, nausea, abdominal discomfort, dark-colored urine, and jaundice (a yellowing of the skin and whites of the eyes ...
openaire +1 more source
Hepatitis A is a liver disease caused by the hepatitis A virus (HAV). The incubation period of hepatitis A is usually 14–28 days. Symptoms of hepatitis A range from mild to severe, and can include fever, malaise, loss of appetite, diarrhea, nausea, abdominal discomfort, dark-colored urine, and jaundice (a yellowing of the skin and whites of the eyes ...
openaire +1 more source
Combined hepatitis A and B vaccines
Drug and Therapeutics Bulletin, 1997Within the last decade, the development of effective monovalent vaccines has provided a major advance in the prevention of both hepatitis A and B. We have previously reviewed these vaccines.1,2 Now, combined (bivalent) hepatitis A and B vaccines have been licensed (▼Twinrix Adult and ▼Twinrix Paediatric-SmithKline Beecham).
openaire +2 more sources
Vaccine, 1998
Currently available hepatitis B vaccines are immunogenic, efficacious and safe. There is no doubt that their consistent use makes the elimination of hepatitis B in most countries possible. Nevertheless, there are still aspects of these vaccines which could be improved: three doses are needed for a full course of vaccination (which is sometimes ...
openaire +2 more sources
Currently available hepatitis B vaccines are immunogenic, efficacious and safe. There is no doubt that their consistent use makes the elimination of hepatitis B in most countries possible. Nevertheless, there are still aspects of these vaccines which could be improved: three doses are needed for a full course of vaccination (which is sometimes ...
openaire +2 more sources
Safety of hepatitis B vaccines
Travel Medicine and Infectious Disease, 2004Although concerns about vaccine safety have increased, true adverse reactions associated with hepatitis B vaccines are few, apart from minor symptoms at the site of injection and occasionally systemic reactions. There is no evidence of an association with hepatitis B vaccination and Sudden Infant Death Syndrome, Multiple Sclerosis and the Chronic ...
openaire +2 more sources